Clinical Trial Status Tracker
Track the research pipeline for 130 peptides. View where each peptide stands in clinical development, filter by category and evidence level, and export data for your research.
Understanding Clinical Trial Phases
Peptides progress through a defined research pipeline. Preclinical studies test safety and mechanisms in animal models. Phase 1 trials evaluate safety in small human groups. Phase 2 trials test efficacy and optimal dosing. Phase 3 trials confirm effectiveness in large populations. Approved peptides have passed regulatory review for specific indications.
How to Interpret Evidence Levels
Evidence levels reflect the quality of available research. "High" evidence includes multiple well-designed human trials. "Moderate" includes some human data alongside preclinical research. "Low" and "very low" evidence indicates primarily preclinical or limited data. Higher evidence does not necessarily mean a peptide is approved for clinical use.
The Gap Between Research and Approval
Many peptides show promising preclinical results but have not progressed to human trials. The journey from preclinical research to regulatory approval typically takes 10-15 years and involves substantial investment. Research status in this tracker reflects published literature, not regulatory classification.
Related Tools
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.